Glaxo lupta pentru preluarea Human Genome Sciences
GlaxoSmithKline (GSK), cea
mai mare compania farmaceutica din Marea Britanie, a lansat o oferta de 2,6
miliarde de dolari (1,6 miliarde de lire) pentru preluarea companiei americane
de medicamente Human Genome Sciences.
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2012/05/4faa4b67a9b45.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/themes/strawberry-daily-202207/assets/images/avatar.png){kind=avatar}
Alte articole
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Nicusor_Dan.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Bolojan-1.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Miruta-Darau.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/DonalD-Trump-3.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Facebook-Ministerul-Finantelor.webp)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Green-Card-SUA.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Nicusor-Dan-6.jpg)
